December 12, 2018
Cambridge, UK and Indianapolis, US – 12 December 2018: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH) announces that data and analyses from its positive Phase 2 clinical trial of APD403 (intravenous and oral amisulpride) in chemotherapy induced nausea and vomiting (CINV) have been published (Herrstedt et al1) in the online edition of...


BONESUPPORT HOLDING AB (publ) announces that the patient enrolment schedule for the ongoing FORTIFY study is extended
21. August 2019
Parkinson-symptomer invaderede fra tarmsystemet
Parkinson’s symptoms invade from the gut
18. July 2019
Muslinge-lim som erstatning for operationstråd
Mussel glue to replace surgical sutures
17. July 2019


Lundbeckfonden Ventures

Lundbeckfonden Emerge